Treatment of Perimenstrual Migraine with Triptans: an Update

被引：0
|
作者：
Barbara Casolla
Luana Lionetto
Serena Candela
Lidia D’Alonzo
Andrea Negro
Maurizio Simmaco
Paolo Martelletti
机构：
[1] Sant’Andrea Hospital,Sapienza University, Advanced Molecular Diagnostic Unit, NESMOS Department
[2] Sant’Andrea Hospital,Sapienza University, Regional Referral Headache Center, Department of Clinical and Molecular Medicine
[3] Massachusetts General Hospital,Stroke and Neurovascular Regulation Laboratory, Department of Radiology
[4] Harvard Medical School,undefined
来源：
Current Pain and Headache Reports | 2012年 / 16卷
关键词：
Menstrual migraine; Pure menstrual migraine; Perimenstrual migraine; Triptans; Perimenstrual short-term prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pure menstrual migraine (PMM) and menstrually related migraine (MRM) are difficult challenges in migraine management. Triptans are a class of highly selective serotonin receptor agonists, which interfere with the pathogenesis of migraine and are effective in relieving the associated neurovegetative symptoms. In recent years triptans have been extensively proposed for the treatment of severe, disabling, and recurrent perimenstrual migraine attacks. This review summarizes the different levels of recommendations for the use of triptans in the treatment of perimenstrual migraine. This review is also intended to offer an updated reasonable guide to physicians treating perimenstrual migraine in daily practice.
引用
收藏
页码：445 / 451
页数：6
相关论文
共 50 条
  • [1] Treatment of Perimenstrual Migraine with Triptans: an Update
    Casolla, Barbara
    Lionetto, Luana
    Candela, Serena
    D'Alonzo, Lidia
    Negro, Andrea
    Simmaco, Maurizio
    Martelletti, Paolo
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2012, 16 (05) : 445 - 451
  • [2] Triptans in the Treatment of Migraine
    Guldiken, Baburhan
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 711 - 713
  • [3] Treatment of hemiplegic migraine with triptans
    Artto, V.
    Nissila, M.
    Wessman, M.
    Palotie, A.
    Farkkila, M.
    Kallela, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (09) : 1053 - 1056
  • [4] Advances in migraine treatment: The triptans
    Spierings, ELH
    [J]. NEUROLOGIST, 2001, 7 (02) : 113 - 121
  • [5] Triptans in the Acute Migraine Management of Children and Adolescents: An Update
    Chatterjee, Jessica Hauser
    Blume, Heidi K.
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (07) : 641 - 649
  • [6] Triptans in the treatment of basilar migraine and migraine with prolonged aura
    Klapper, J
    Mathew, N
    Nett, R
    [J]. HEADACHE, 2001, 41 (10): : 981 - 984
  • [7] Efficacy of Lasmiditan for the Acute Treatment of Perimenstrual Migraine
    MacGregor, A.
    Komori, M.
    Krege, J.
    Dong, Y.
    Vincent, M.
    Hauck, P.
    Igarashi, H.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 146 - 146
  • [8] Efficacy of lasmiditan for the acute treatment of perimenstrual migraine
    MacGregor, E. Anne
    Komori, Mika
    Krege, John Henry
    Baygani, Simin
    Vincent, Maurice
    Pavlovic, Jelena
    Igarashi, Hisaka
    [J]. CEPHALALGIA, 2022, 42 (14) : 1467 - 1475
  • [9] The safety of triptans in the treatment of patients with migraine
    Jamieson, DG
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (02): : 135 - 140
  • [10] Acute treatment of migraine and the role of triptans
    Freitag F.G.
    [J]. Current Neurology and Neuroscience Reports, 2001, 1 (2) : 125 - 132
12345